Investment Overview

Sigachi Laboratories Limited is an unlisted company operating in the Health Care sector (Pharmaceuticals / Lab Services). Sigachi Laboratories Limited is an Indian pharmaceutical company referenced for manufacturing active ingredients and intermediates, complementing the broader Sigachi group known for excipients. Public materials cite capabilities in compliant production, quality control and customer documentation to …

Strengths

• : Debt-Free Activities – No borrowings, which reduces financial hazard and interest burden.
• : Global Footprint – Wide international establishment ensures diversified earnings streams.
• : Strong Certifications – Trusted by global clients due to stringent quality and compliance standards.

Key Risks

• : Declining Margins – OPM and EBIT margins have declined over the years, hinting at cost pressures.
• : High Other Expenses – A major jump in other expenses in 2024 may outcome future profitability.
• : Zero Inventory & Trade Payables – Lack of visible data here may raise transparency questions for investors.

Valuation View

The current unlisted market price is ₹51.48 per share with a market capitalisation of approximately ₹35 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.